Release Date: 3/2/26
The 2nd Annual Cleveland Clinic Cancer Conference features the latest advances in the diagnosis and management of the most prevalent cancers at all stages of disease and treatment. A world renowned faculty provide disease specific, evidence-based, practical presentations representing a variety of medical disciplines. This includes current and future strategies for cancer care, while detailing the role of emerging technologies, support and non-pharmacologic therapeutics for the cancer patient.
Topics include: Hematologic malignancies, myeloma, amyloidosis, tumor boards, genomics, precision oncology, lung cancer, palliative care, AI, novel therapies, gynecologic cancers, sarcoma, melanoma, GI cancers, breast cancer and much more.
Theme: Innovations in Multidisciplinary Care.
Location: Margaritaville Hollywood Beach Resort, Hollywood, FL (and streaming via Meetings By Mail).
Target Audience: Medical oncologists, hematologists, radiation oncologists, and other oncology professionals.
Key Topics: Hematological malignancies, genomics, precision oncology, AI in cancer care, gynecological cancers, sarcoma, and palliative care.
+ Topics:
Session 1 – Updates and State of the Art Therapy in Hematologic Malignancies
Advances in the Management of Myeloproliferative Neoplasm
Yehuda Galili, MD
Recent Advances in MDS and AML: What’s Practice Changing?
Akriti Jain, MD
Advances in the Management of Myeloma/AL Amyloidosis
Jack Khouri, MD
Tumor Boards Case Panels
Betty Hamilton, MD; Alex Mejia Garcia, MD
Session 2 – Genomics/Precision Oncology
Genetic Testing: What Oncologists Should Know
Sara Rhode, MS, CGC
The Future of AI in Cancer Care
Ali Zarrinpar, MD, PhD
The Power of Minimal Residual Disease Monitoring in Personalized Cancer Care
Shlomo Koyfman, MD
Precision Oncology Case Presentation and Panel Discussion
Jacob Miller, MD
Session 3 – Updates and State of the Art Therapy in Lung Cancer
Surgical Challenges After Neo-Adjuvant Therapy
Monisha Sudarshan, MD, MPH
Treatment of Early-Stage and Locally Advanced NSCLC
Suresh S. Ramalingam, MD
Special Issues in Managing Metastatic NSCLC
Khaled Hassan, MD
Current Management of Small Cell Lung Cancer
Lukas Delasos, DO
Tumor Boards Case Panels
Khaled Hassan, MD; Diana Saravia, MD
Session 4 – Key Issues in Palliative Care
Cancer Related Anorexia-Cachexia Syndrome and Cancer Related Fatigue: Evidence Based Management and Emerging Treatments
Nivia Ruiz, MD
Acupuncture’s Role in Cancer-Related Symptom Management
Thuy Nguyen, DAOM, LAc
Benzodiazepines: Friend or Foe?
Kaleena Chilcote, MD
Cancer Therapy-Induced Neuropathy Management
Renato Samala, MD
Tumor Boards Case Panels
Laura Shoemaker, DO
Session 5 – Novel Therapies
Antibody Drug Conjugate: Innocent Bystander?
Wen Wee Ma, MBBS
CAR-T Cells and Cellular Therapy
Paolo Caimi, MD
Innovations in Anti-Cancer RNA Therapeutics
Natalie Silver, MD
When to Watch and Wait vs. Refer to Surgery: Best Practices for Defining cCR After TNT
Emre Gorgun, MD
Tumor Boards Case Panels
Wen Wee Ma, MBBS; Natalie Silver, MD
Session 6 – Updates and State of the Art Therapy in Selected Solid Tumors
Multidisciplinary Management of Gynecologic Cancers
Robert DeBernardo, MD
Advancing Sarcoma Therapy: Integrating Immunotherapy, Cellular Strategies and Targeted Payloads
Dale Shepard, MD, PhD
Melanoma
James Isaacs, MD
State of the Art Therapy in Head/Neck and Non-Melanoma Skin Cancers: Updates in Particle Therapy and Perioperative Immunotherapy
Jacob Miller, MD
Tumor Boards Case Panels
Robert DeBernardo, MD; Sudha Amarnath, MD
Session 7 – Updates and State of the Art Therapy in GI Cancers
Early-Onset Colorectal and Other GI Cancers: Implications for Diagnosis and Treatment
Alok Khorana, MD
Novel Surgical Strategies in Colorectal Liver Metastases
Federico Aucejo, MD
Shifting Treatment Paradigms in Gastro-Esophageal Cancers
Suneel Kamath, MD
Tumor Boards Case Panels
Matthew Walsh, MD; Alok Khorana, MD
Session 8 – Breast Cancer
Breast Surgery Update
Stephen Grobmyer, MD
Breast Radiation Oncology Updates
Praveen Pendyala, MD
Advances in Adjuvant Therapy for Breast Cancer
Erin Roesch, MD
Latest Updates on the Management of Metastatic Breast Cancer: Antibody -Drug Conjugates for Advanced Stage Disease
Rita Nanda, MD
Tumor Boards Case Panels
Megan Kruse, MD; Stephen Grobmyer, MD




Reviews
There are no reviews yet.